You are here

Press releases

21.10.2019

Barcelona, October 21, 2019.- Boehringer Ingelheim, one of the top 20 pharmaceutical companies in the world, has become a partner of Design Health Barcelona (d·HEALTH Barcelona), the postgraduate program promoted by Biocat to train future innovators and entrepreneurs in the healthcare sector.

Following the biodesign methodology created by Stanford University, the participants in d·HEALTH Barcelona experience a...

16.05.2019

Barcelona, May 16, 2019. Start-ups in the BioRegion of Catalonia, the Catalan healthcare and life sciences sector, attracted a joint total of €106.1 million in funding in 2018, up 1.9% from the previous year. More than half of this investment (€61.3 million) was from venture capital funds. Furthermore, three in four euros in venture capital attracted by Catalan biomedical start-ups (75%) came from rounds with foreign participation.

In this context, on May 20 and 21, Barcelona is hosting Bio€quity Europe 2019, the main event for biomedicine investors in...

06.05.2019

Barcelona, May 6, 2019.- 10 international projects have been chosen to participate in the 2nd edition of CRAASH Barcelona, the acceleration program Biocat organizes with CIMIT (Boston), the most experienced health accelerator in the world, and in collaboration with EIT Health, the main European healthcare consortium.

The 10 projects chosen to...

16.01.2019

Barcelona, January 16, 2019.- Biocat has opened the call for applications to the second edition of CRAASH Barcelona, a 12-week acceleration program that helps research teams from Catalonia and other European countries successfully launch innovation to market in the healthtech arena. The deadline for applications is 13 March and they must be submitted through the website (www.craashbarcelona.org). The program will begin in...

05.11.2018

Biocat has launched the latest edition of the Biocat Report, the benchmark study on the healthcare and life sciences sector in Catalonia. This sector generates €31.087 billion each year and makes up 7.2% of the gross domestic product (GDP). In total, more than 223,000 people are employed in the sector, roughly 7% of all those working in Catalonia....

26.06.2018

Bio€quity Europe, the longest running, independent investor event serving the European biopharma industry, will take place in Barcelona for the first time on May 20-21, 2019. It provides a forum for the international venture capital communities to establish relationships with the management teams of hand-picked companies selected by BioCentury with promising investment prospects.

Bio€quity Europe – which is organized by BioCentury and EBD Group -- is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to...